This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slid 7.8% to $25.80 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.4% to 18,872.64 and Dow Jones Industrial Average falling 1.9% to 41,860.44.
The stock's fall snapped a three-day winning streak.
Moderna Inc. closed 84.9% short of its 52-week high of $170.47, which the company achieved on May 24th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 0.3% to $153.18, Pfizer Inc. fell 2.0% to $23.04, and Gilead Sciences Inc. fell 1.27% to $107.72.
Trading volume totaled 17.6 million, compared to the 50-day average of 10.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 21, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.